Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,409,523
+$9,121,378 QoQ
Shares Held
217,739
+236.5% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 421 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,988,618 | $286,622,087 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
219,094 | $118,711,701 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,929,853 | $65,383,418 | |
| 4 | VTRS |
Viatris Inc
|
3,269,550 | $51,920,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
220,463 | $37,156,833 | |
| 6 | ALKS |
Alkermes plc.
This page
|
217,739 | $11,409,523 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
82,089 | $9,106,952 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
31,793 | $2,631,824 |
All Filings in ALKS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,409,523 | 217,739 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,288,145 | 64,710 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $906,076 | 32,383 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $882,300 | 29,410 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $773,042 | 27,020 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,223,731 | 67,345 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,406,147 | 83,663 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $7,430,391 | 265,466 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,114,107 | 336,685 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,355,750 | 308,672 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,458,012 | 124,658 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,456,714 | 123,410 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $464,992 | 14,856 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $511,225 | 18,135 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $408,934 | 15,650 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,904,414 | 85,285 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $2,488,880 | 80,703 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,397,271 | 97,768 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||